The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 09, 2018

Filed:

Jun. 27, 2012
Applicants:

Cynthia Chin, Madison, WI (US);

Anthony D. Person, Madison, WI (US);

Gary A. Dahl, Madison, WI (US);

Inventors:

Cynthia Chin, Madison, WI (US);

Anthony D. Person, Madison, WI (US);

Gary A. Dahl, Madison, WI (US);

Assignee:

CellScript, LLC., Madison, WI (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 21/02 (2006.01); C12N 5/078 (2010.01); A61K 38/16 (2006.01); C07K 14/705 (2006.01); C07K 14/715 (2006.01); A61K 31/7105 (2006.01); A61K 38/17 (2006.01); A61K 38/21 (2006.01); C07K 14/005 (2006.01); A61K 31/711 (2006.01); C12N 5/077 (2010.01); C12N 5/074 (2010.01); A61K 48/00 (2006.01); C07H 21/02 (2006.01); C12P 19/34 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0634 (2013.01); A61K 31/711 (2013.01); A61K 31/7105 (2013.01); A61K 38/162 (2013.01); A61K 38/1774 (2013.01); A61K 38/21 (2013.01); C07K 14/005 (2013.01); C07K 14/70503 (2013.01); C07K 14/7156 (2013.01); C12N 5/0658 (2013.01); C12N 5/0696 (2013.01); C12N 2710/20022 (2013.01); C12N 2710/22022 (2013.01); C12N 2710/24122 (2013.01); C12N 2760/16122 (2013.01);
Abstract

The present invention provides methods, kits, and compositions for reducing an innate immune system response in a human or animal cell, tissue or organism. One embodiment comprises: introducing an Agent mRNA comprising in vitro-synthesized mRNA encoding one or more proteins that affect the induction, activity or response of an innate immune response pathway; whereby, the innate immune response in the cell, tissue or organism is reduced compared to the innate immune response in the absence of the Agent mRNA. Other embodiments are methods, compositions and kits for using an Agent mRNA for treating a disease or medical condition in a human or animal that exhibits symptoms of an elevated innate immune system, or for reducing an innate immune response that is induced in a human or animal cell, tissue or organism by a Foreign Substance that is administered to the cell, tissue or organism.


Find Patent Forward Citations

Loading…